The ability to transactivate from transfected p21-5′ REs was assessed in p53 null SaOS2 cells (derived from a human osteosarcoma line) that were transfected with a cytomegalovirus (CMV) based p53 expression plasmid [65]. This evidence concerns the gene TP53 and osteosarcoma.